Christopher Simon - 12 May 2023 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Reporting relationship: President & CEO, Director
Issuer ticker: HAE
Reported as of: 12 May 2023
Net transaction value: -$75,289
SEC form: 4
Accepted by SEC: 16 May 2023, 16:15:17 UTC
Prior SEC filing: 15 Nov 2022
Next SEC filing: 17 May 2023
Source filing: View source filing
Reporting owner signature: /s/ Thomas V. Powers, attorney-in-fact for Mr. Simon

Key filing fact

Christopher Simon filed Form 4 for HAEMONETICS CORP (HAE) on 16 May 2023.

Key facts

This page summarizes Christopher Simon's Form 4 filing for HAEMONETICS CORP (HAE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 May 2023, 16:15.

Change

Previous filing in this sequence was filed on 15 Nov 2022.
Current net transaction value: -$75,289.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HAE transaction

Common Stock

Tax liability

Transaction value: $75,289
Shares: -854
Change %: -0.42%
Price: $88.16
Shares after: 204,567
Date: 12 May 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

Footnote F2

This number includes unvested RSUs previously reported as well as 297 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 28, 2023.